HS Code:
N-[1-[(6-Chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide, commonly known as Imidacloprid (CAS No. 138261-41-3), is a systemic insecticide belonging to the neonicotinoid class. It is widely used in agriculture for pest control on crops such as cereals, fruits, vegetables, and ornamental plants. Classified under HS Code 2933.39.27, it falls within the category of heterocyclic compounds with nitrogen hetero-atoms. Imidacloprid works by interfering with the nervous system of insects, making it effective against a broad spectrum of pests, though it has faced scrutiny due to its environmental impact, particularly on pollinators like bees.
Total Trade Volume
Approximately $1.2 billion USD
Data from 2022
Source
UN Comtrade Database, International Trade Centre (ITC)
$450 million USD
37.5% of total trade of total trade
Increasing
$300 million USD
25.0% of total trade of total trade
Stable
$150 million USD
12.5% of total trade of total trade
Increasing
$100 million USD
8.3% of total trade of total trade
Decreasing
$80 million USD
6.7% of total trade of total trade
Stable
Average Rate
5.5% ad valorem
Highest Rate
10% (applied by certain developing countries)
Lowest Rate
0% (under free trade agreements like EU-USMCA)
Declining demand in Europe due to regulatory bans
Shift in market focus to Asia-Pacific and Latin America where regulations are less stringent
2021-2022
Rising production of generic Imidacloprid post-patent expiry
Increased competition and price reduction, benefiting farmers but challenging original manufacturers
2020-2022
Growing demand for sustainable alternatives
Pressure on Imidacloprid market as biopesticides and organic farming gain traction
2022
The European Union extended restrictions on Imidacloprid use in open-field applications to protect pollinators, limiting its market in member states.
April 2023
Significant reduction in EU imports; manufacturers redirecting supply to non-EU markets.
Recent research highlighted Imidacloprid's long-term effects on soil and water ecosystems, prompting calls for stricter global regulations.
July 2023
Potential for additional bans or restrictions in key markets like Canada and Australia.
Chinese manufacturers increased Imidacloprid production to meet rising demand in Asia and Africa, capitalizing on lower production costs.
January 2023
Strengthened Chinaโs position as the leading exporter, potentially driving down global prices.